NK VUE
Live / Registered — Registered and renewed (as of 17 Sept 2026)
What this means for you
Registered since 05 Jul 2016. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 05 Jul 2036: the §8 & §9 renewal).
Record
- Serial number
- 86300720
- Registration number
- 4993881
- Mark type
- Word mark
- Filed
- 04 Jun 2014
- Published for opposition
- 18 Aug 2015
- Registered
- 05 Jul 2016
- Current term from
- 05 Jul 2026
- Next maintenance filing
- §8 & §9 renewal, due by 05 Jul 2036 (grace period to 05 Jan 2037)
- Attorney of record
- Deborah L. Corpus
Goods and services
- Class 001 — Chemicals: NK cell activation testing kits containing peptide substrates used in analyzing and detecting certain toxins for clinical, research or medical laboratory use; diagnostic kits for clinical laboratory use, namely, kits consisting primarily of monoclonal antibodies and/or recombinant proteins [ , RNA, DNA ] for use in disease diagnosis, screening, monitoring, prognosis, and immune status; diagnostic kits for medical laboratory use, namely, kits consisting primarily of monoclonal antibodies and/or recombinant proteins [ , RNA, DNA ] for use in disease diagnosis, screening, monitoring, prognosis, and immune status; diagnostic kits for medical research use, namely, kits consisting primarily of (monoclonal antibodies and/or recombinant proteins [ , RNA, DNA ] for use in disease diagnosis, screening, monitoring, prognosis, and immune status; diagnostic kits for clinical research use, namely, kits consisting primarily of monoclonal antibodies and/or recombinant proteins [ , RNA, DNA ] for use in disease diagnosis, screening, monitoring, prognosis, and immune status; diagnostic preparations for clinical laboratory use and medical laboratory use; diagnostic preparations for clinical research use other than for medical use; diagnostic reagents for clinical laboratory use, medical laboratory use, medical research use and clinical research use
- Class 005 — Pharmaceuticals: diagnostic kits for medical diagnostic use, namely, kits consisting primarily of monoclonal antibodies and/or recombinant proteins [ , RNA, DNA ] for use in disease diagnosis, screening, monitoring, prognosis, and immune status; diagnostic activators in the nature of proteins for use in diagnostic kits for disease diagnosis, screening, monitoring, prognosis, and immune status; diagnostic preparations for medical diagnostic use; diagnostic reagents for medical diagnostic use
Owner
- NKGEN BIOTECH KOREA CO., LTD, GYEONGGI-DO, KR
- NKMAX CO., LTD., SEONGNAM-SI, GYEONGGI-DO, KR
- ATGen Co., Ltd., Gyeonggi-do 463-400, KR
- ATGen Co., Ltd., Gyeonggi-do 463-400, KR
- ATGen Co., Ltd., Gyeonggi-do 463-400, KR
Prosecution history
- 29 Dec 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 29 Dec 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 29 Dec 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 29 Dec 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 29 Dec 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 05 Jul 2025 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 04 Feb 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 04 Feb 2023 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 04 Feb 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 03 Aug 2022 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 19 Jul 2022 — TEAS SECTION 8 & 15 RECEIVED
- 05 Jul 2021 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 02 Dec 2016 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 05 Jul 2016 — REGISTERED-PRINCIPAL REGISTER
- 02 Jun 2016 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED